Who
John Gordon Freund
Director
Company insider
Files Form 4 as: Director and 10% owner, Si-Bone; Director and 10% owner, Collegium Pharmaceutical; Director and 10% owner, Sutro Biopharma; Director and 10% owner, Tetraphase Pharmaceuticals; Director and 10% owner, Protara Therapeutics; Director, Xenoport; Other, Dicerna Pharmaceuticals; Director and 10% owner, Concert Pharmaceuticals.
In numbers
- Trades disclosed
- 325
- Buys
- 21
- Sells
- 50
- Bought
- $480.8B
- Sold
- $110.3M
- Companies
- 12
- Companies where not an officer
- 12
- First trade
- 2 May 2006
- Last trade
- 4 Jun 2026
- Last filed
- 8 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 4 Jun 2026filed 8 Jun 2026 | SIBN Si-BoneMedical Devices | SEC FORM 4 Code A | —10,957 at $0.00 | filing |
| 4 Jun 2026filed 8 Jun 2026 | SIBN Si-BoneMedical Devices | SEC FORM 4 Code A | —10,957 at $0.00 | filing |
| 18 May 2026filed 20 May 2026 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Sold | $68120 at $34.05 | filing |
| 18 May 2026filed 20 May 2026 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Sold | $68120 at $34.05 | filing |
| 15 May 2026filed 18 May 2026 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Code M | $143K8,700 at $16.49 | filing |
| 15 May 2026filed 18 May 2026 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Sold | $143K4,127 at $34.54 | filing |
| 15 May 2026filed 18 May 2026 | COLL Collegium Pharmaceuticaloption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —8,700 at $0.00 | filing |
| 15 May 2026filed 18 May 2026 | COLL Collegium Pharmaceuticaloption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —8,700 at $0.00 | filing |
| 15 May 2026filed 18 May 2026 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Code M | $143K8,700 at $16.49 | filing |
| 15 May 2026filed 18 May 2026 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Sold | $143K4,127 at $34.54 | filing |
| 14 May 2026filed 18 May 2026 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Code A | —8,741 at $0.00 | filing |
| 14 May 2026filed 18 May 2026 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Code A | —8,741 at $0.00 | filing |
| 8 Aug 2025filed 12 Aug 2025 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Sold | $401K11,659 at $34.36 | filing |
| 8 Aug 2025filed 11 Aug 2025 | SIBN Si-BoneMedical Devices | SEC FORM 4 Sold | $194K12,132 at $15.99 | filing |
| 9 Jun 2025filed 11 Jun 2025 | COLL Collegium Pharmaceuticaloption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —15,000 at $0.00 | filing |
| 9 Jun 2025filed 11 Jun 2025 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Code M | $202K15,000 at $13.45 | filing |
| 9 Jun 2025filed 11 Jun 2025 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Sold | $202K6,601 at $30.62 | filing |
| 5 Jun 2025filed 6 Jun 2025 | SIBN Si-BoneMedical Devices | SEC FORM 4 Code A | —8,675 at $0.00 | filing |
| 15 May 2025filed 19 May 2025 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Code A | —9,791 at $0.00 | filing |
| 26 Jun 2024filed 27 Jun 2024 | SIBN Si-BoneMedical Devices | SEC FORM 4 Code A | —8,791 at $0.00 | filing |
News
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Stock Has Consensus Price Target of $48.71COLL · dailypolitical.com · 13 Oct 2026
0 headlines in the last 90 days name John Gordon Freund; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.